Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Opportunity. The biggest takeaway from the quarter is the tremendous amount of opportunity available to NN. The pipeline in the key end markets-Data Center and Electric Grid, Defense and Electronics, and Medical-exceeds $270 million, with an overall pipeline of $750 million, and the prospect list is over $1 billion in additional opportunities being tracked that have yet to be quoted.
Growth. New-business awards totaled $106 million through September, and management expects more than 150 program launches during 2026. Data-center cooling, defense products, and robotic surgery components are expanding NN’s addressable applications. Management raised its full-year awards target to $110 million to $130 million.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Quarterly Overview. NN delivered a strong 3Q26, significantly exceeding our expectations for sales, adjusted EBITDA, and adjusted net income. NN’s new business program has continued to outperform expectations, with the Company now winning more than 1 new program per day. And NN’s 5 Pillar growth program is working well, with the Company investing its time and resources to strategically pivot the portfolio to high-growth, high-value markets and products.
3Q26 Numbers. Net sales for 3Q26 were $131.1 million, an increase of 26.2% compared to net sales of $103.9 million for 3Q25. The increase was primarily driven by higher selling prices, higher volumes, and favorable foreign exchange effects. Adjusted EBITDA was $18.5 million, an increase of 49.7% compared to adjusted EBITDA of $12.4 million for the same period in 2025. Adjusted net income was $5.3 million, or $0.07 per diluted common share, an increase of $5.6 million or $0.08 per diluted common share, y-o-y.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
NN Delivers Another Quarter of Growth in Net Sales, Adjusted EBITDA, and New Wins; Raises 2026 Outlook Again
CHARLOTTE, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), an entrepreneurial growth company that engineers and manufactures high-precision components and assemblies, today reported results for the third quarter ended September 30, 2026.
Q3 2026 Financial Highlights, compared to Q3 2025
Net sales of $131.1 million, up $27.2 million or 26.2%
Gross margin of $18.3 million, up $0.8 million or 4.6%
Adjusted gross margin of $25.3 million, up $5.8 million or 29.5%
Adjusted gross margin percentage of 19.3%, up 50 basis points
Loss from operations of $3.3 million, up $1.1 million from a loss of $2.2 million
Adjusted income from operations of $8.5 million, up $4.4 million or 109.5%
GAAP net loss of $4.6 million, improving by $2.1 million or 31.3%
Adjusted net income of $5.3 million, up $5.6 million
Adjusted EBITDA of $18.5 million, up $6.1 million or 49.7%
Adjusted EBITDA margin percentage of 14.1%, up 220 basis points
Performance Highlights:
During 2026, NN has completed a multi-step process to transform its balance sheet. The preferred stock payoff and equity raise has unlocked growth potential. NN now has the financial flexibility to accelerate and optimize its business results. The Company had been severely constrained by its capital structure for multiple years. The Company looks forward to achieving higher results at a faster pace.
NN’s new business program has continued to outperform expectations. On a trailing 12 months basis ended September 30, 2026, the Company has secured $130 million of annualized new business awards, a significant portion of which is not yet reflected in the Company’s run-rate. The Company is now winning more than 1 new program per day. The Company will continue to update results during quarterly earnings calls.
NN’s 5 Pillar growth program is working well and the Company is investing its time and resources to strategically pivot the portfolio to high-growth, high-value markets and products. The Company has been aided by strong underlying market growth.
Data Center: NN’s top targeted end market and one of its fastest growing businesses. NN is ramping up the business by installing over 50 new machines dedicated to this market through Q1 2027. This business has a growing $66 million pipeline, including liquid cooling components for next generation chip designs.
Defense: NN has secured multiple new awards in this market in 2026 and recently became a supplier to a leading firearm accessories OEM with multiple programs currently in ramp-up mode.
Medical: NN has secured multiple new awards in this market in 2026 and became a supplier to a leading medical equipment OEM with 30 core platforms. The Company is significantly increasing the size of the business with multiple programs in ramp-up mode.
NN’s cost-out program is on track to deliver $12 million of cost-out via 335 projects globally. These cost improvements are not yet fully reflected in the Company’s run-rate results. NN’s global operations team is also leading an ongoing continuum of new product development and business launches. In 2026, NN expects to launch more than 150 new programs worth approximately $100 million in peak annual sales.
NN is underway with an intentional sales growth investment program. Overall, the Company is growing its net sales by approximately $68 million in 2026 based on updated guidance. The Company has achieved excellent working capital performance of 16.5% – 16.7% of sales over the trailing 6 months.
Management Commentary:
Harold Bevis, President and Chief Executive Officer, commented, “NN has delivered several consecutive years of improved adjusted EBITDA and sales growth wins, is now benefitting from the launching of these programs, and has a solid multi-year outlook for continued growth. This enabled the Company to initiate a transformation of its equity and debt structure. We paid off all of our preferred stock via several debt-for-equity transactions over the last 4 months. We also raised strategic capital to fund additional programs that were previously on hold due to lack of funding. Taken together, this represented $143 million of capital transactions. We executed decisively and I want to thank our Board of Directors, our new investors, and our advisors. This transformation is behind us now and we are already underway leveraging our newly enhanced flexibility.
We are operating under a new reality whereby we can move faster and improve on multiple fronts at once. While we are on track for our best year ever in 2026, our momentum is continuing into 2027, as part of an achievable multi-year growth outlook. We have a full basket of opportunities to improve, and we are taking on the next set of big improvements during 2027 now that we have the financial capacity to do so. The last remaining balance sheet financial improvements are with regards to our ABL and Term Loan, which we will fix at the right time.
While we are happy with our last four years of sustained results improvement, we are at the same time determined to continue elevating the business to a higher plane of performance. This will require us to continue shifting our portfolio. We are taking forward actions on targeted sales growth, exiting low profit auto programs, and continuously taking out costs. We are on track for our multi-year targets. We are pleased that we have secured many new customers and introduced multiple new products in 2026. Further, we have a refreshed investor roster with growth-minded investors aligned with our forward goals. We are already accelerating our pace of improvement with our newfound financial flexibility.”
Bevis continued, “Our 5 Pillar growth program is our touchstone. Now we are in a position to also explore logical, small bolt-on acquisitions to further enhance our goals and growth trajectory. We are pleased that many of our new sales programs require ‘Immediate Startup’. Overall, the new wins numbers are very good, but we have areas where we want a significantly higher level of wins and growth, especially Data Center, Medical, and Defense. We are disciplined about improving our margins at the same time, walking away from dilutive business, and exiting minimal margin, minimal ROI business. We believe we have more room to increase our gross margins, adjusted EBITDA margins, and ROIs.”
Bevis concluded, “Given the results we have delivered in 2026 year to date and our strong forward outlook, we are raising our full-year 2026 guidance. We will be more specific about 2027 when we have completed our 2027 business planning process which is underway now. We are updating our thinking now that we have more financial firepower that has been enabled by our balance sheet transformation of 2026.”
Third Quarter NN Results
Net sales for the third quarter were $131.1 million, an increase of 26.2% compared to net sales of $103.9 million for the same period in 2025. The increase was primarily driven by higher selling prices, reflecting the pass-through of increased raw material costs to customers, higher volumes, and favorable foreign exchange effects.
Loss from operations for the third quarter was $3.3 million, an increase of $1.1 million compared to a loss from operations of $2.2 million for the same period in 2025. The decline was primarily due to higher labor costs associated with increasing headcount to support new business and higher professional fees driven by the various strategic initiatives.
Net loss for the third quarter was $4.6 million, an improvement of 31.3% compared to net loss of $6.7 million for the same period in 2025. The improvement was primarily driven by a gain related to a favorable tax ruling in Brazil and higher income from our joint venture in China.
Third Quarter 2026 NN Adjusted Results
Adjusted EBITDA was $18.5 million, an increase of 49.7% compared to adjusted EBITDA of $12.4 million for the same period in 2025, primarily driven by improved sales mix, operating performance and higher income from our joint venture in China.
Adjusted income from operations was $8.5 million, an increase of 109.5% compared to adjusted income from operations of $4.0 million for the same period in 2025. The increase was driven primarily by higher volumes and improved mix to higher margin products, partially offset by increased selling, general and administrative expenses.
Adjusted net income was $5.3 million, or $0.07 per diluted common share, an increase of $5.6 million or $0.08 per diluted common share, compared to adjusted net loss of $0.3 million, or $(0.01) per diluted common share for the same period in 2025.
Third Quarter Power Solutions Results Net sales for the third quarter of 2026 were $63.2 million, an increase of 40.6% compared to net sales of $44.9 million for the same period in 2025. The increase was driven primarily by higher selling prices, reflecting the pass-through of increased raw material costs to customers, increased volumes, and favorable foreign exchange effects.
Income from operations for the third quarter of 2026 was $9.2 million, an increase of 69.4% compared to income from operations of $5.4 million for the same period in 2025. The increase was primarily due to higher selling prices and increased volumes. The increase was partially offset by higher material costs and labor costs.
Adjusted income from operations for the third quarter of 2026 was $12.4 million, an increase of 53.1% compared to adjusted income from operations of $8.1 million for the same period in 2025. The increase was primarily due to the improved operating performance from higher selling prices and volumes.
Third Quarter Mobile Solutions Results
Net sales for the third quarter of 2026 were $68.2 million, an increase of 15.3% compared to net sales of $59.1 million in the same period of 2025. The increase was primarily due to higher volumes and favorable foreign exchange effects.
Loss from operations for the third quarter was $6.3 million, a decline of $3.4 million compared to $2.9 million for the same period in 2025. The increase was primarily due to higher costs from volume increases, increased labor costs due to the start-up of new programs, material cost increases, and facility costs.
Adjusted income from operations for the third quarter was $4.0 million, an increase of 75.2% compared to adjusted income from operations of $2.3 million in the same period of 2025. The increase in adjusted income from operations was primarily due to higher sales volumes and increased net income from our joint venture.
2026 Outlook NN is revising its guidance ranges upward in several areas.
Net sales are expected to range between $480 to $500 million
This reflects a $68 million improvement over 2025, or 16% growth year-over-year at the midpoint.
Adjusted EBITDA is expected to range between $64 and $68 million.
This reflects a $17 million improvement over 2025, or 35% growth year-over-year at the midpoint.
New business wins are expected to range between $110 to $130 million.
This reflects a $50 million improvement over 2025, or 71% growth year-over-year at the midpoint.
Chris Bohnert, Senior Vice President and Chief Financial Officer, commented, “Given the strength of our results year to date and the continued momentum in our targeted growth markets, we are again raising our full-year 2026 guidance across our key metrics. As we look ahead to the final quarter of 2026 and into 2027, our outlook reflects continued profitable growth and keeps us well on track to maintain pace with our 2029 financial goals. Our new capital structure enables NN to enter 2027 with a stronger balance sheet and greater financial flexibility to invest in our growth.”
Conference Call
NN will discuss its results during its quarterly investor conference call on October 29, 2026, at 9 a.m. ET. The call and supplemental presentation may be accessed via NN’s website, www.nninc.com. The conference call can also be accessed by dialing (833) 461-5787 (domestic) or (585) 542-9983 (international) and entering Conference ID number 100337183. For those who are unavailable to listen to the live broadcast, a replay will be available shortly after the call.
NN discloses in this press release the non-GAAP financial measures of adjusted gross margin, adjusted gross margin %, adjusted income from operations, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), and adjusted net income (loss) per diluted common share. Each of these non-GAAP financial measures provides supplementary information about the impacts of acquisition, divestiture and integration related expenses, foreign-exchange impacts on inter-company loans, reorganizational and impairment charges.
The financial tables found later in this press release include a reconciliation of adjusted gross margin, adjusted gross margin %, adjusted income from operations, adjusted operating margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), and adjusted net income (loss) per diluted common share to the U.S. GAAP financial measures of gross margin, income (loss) from operations, net loss, net loss per diluted common share.
About NN, Inc.
NN, Inc. (NASDAQ: NNBR) is an entrepreneurial manufacturing company specializing in manufacturing micron-tolerance precision metal componentry for high-growth end markets, especially Data Center, Electric Grid, Medical, Defense, and High-Value Vehicle systems. Founded in 1980, NN serves over 700 customers on 4 continents through its 2,700 person workforce operating out of 27 global plants. This footprint enables rapid innovation and globally scaled solutions. For more information, visit nninc.com.
This press release may contain forward-looking statements regarding our business, operations, and financial performance. Such statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties. Actual results could differ materially. Please refer to our most recently filed Form 10-K and our Form 10-Q for the period following that Form 10-K, including the risk factors described therein. We undertake no obligation to update any forward-looking statement, except as required by law. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements.
Investor & Media Contacts: Joseph Caminiti [email protected] 312-445-2870
CHARLOTTE, N.C., Oct. 08, 2026 (GLOBE NEWSWIRE) — NN, Inc. (“NN” or the “Company”) (NASDAQ: NNBR), a global leader in precision manufacturing, today announced that it had completed an important balance sheet transaction.
The Company has redeemed, paid off and eliminated all of its remaining 18,400 outstanding shares of its Series D Perpetual Preferred Stock, par value $0.01 per share (the “Preferred Stock”) for approximately $30.7 million.
The redemption was funded with proceeds raised from the Company’s $53.1 million private investment in public equity (PIPE) private placement completed on October 5, 2026. Additionally, the timing of this action enabled the Company to take advantage of a $5.0 million incentive provided under a prior agreement with the sole holder of the security. Thus, the $35.7 million value of the security was redeemed for $30.7 million.
This security has now been eliminated from NN’s balance sheet. No shares of the Preferred Stock remain outstanding. All of the holder’s rights associated with the Preferred Stock have also been eliminated. This completes an important stepping stone in the transformation of NN, its capital structure, and its business plan.
Harold Bevis, President and CEO of NN, commented, “NN has significantly deleveraged during 2026. We will use this newly created capital flexibility to accelerate our business plans. We also intend to refinance our Term Loan at the right time and further improve our capital structure. The Company will provide updated guidance during our next earnings call on October 29th, 2026.”
About NN, Inc.
NN, Inc. (NASDAQ: NNBR) is an entrepreneurial manufacturing company specializing in manufacturing micron-tolerance precision metal componentry for high-growth end markets, especially Data Center, Electric Grid, Medical, Defense, and High-Value Vehicle systems. Founded in 1980, NN serves over 700 customers on 4 continents through its 2,700 person workforce operating out of 27 global plants. This footprint enables rapid innovation and globally scaled solutions. For more information, visit nninc.com.
Forward Looking Statements
This press release may contain forward-looking statements regarding our business, operations, and financial performance. Such statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties. Actual results could differ materially. Please refer to our most recently filed Form 10-K and our Form 10-Q for the period following that Form 10-K, including the risk factors described therein. We undertake no obligation to update any forward-looking statement, except as required by law. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Transaction. As noted, NN is eliminating its outstanding Preferred stock, which will eliminate the associated dividends that cost the Company approximately $19 million in 2025. NN issued 11.3 million shares in the PIPE transaction and an additional 4.8 million pre-funded warrants. Eliminating the dividends and increasing the share count would lower our 4Q26 estimated loss per share to $0.03 from a prior $0.06. The elimination of $122.1 million of outstanding preferred stock as of June 30th significantly improves NN’s capital structure.
Term Loan. At the end of June, NN had $133.5 million outstanding under its term loan facility at a 13.5% interest rate. We believe the elimination of the preferred, along with solid operating performance, gives management the opportunity to refi the term debt at a lower rate. For illustrative purposes, reducing the interest rate to 10% from 13.5% would save the Company $4.6 million in annual interest costs, or about $0.04/sh, based on 100 million shares outstanding.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
A Raise. For the third time in 2026, NN management raised full-year guidance, reflecting the positive momentum of the business, in our view. Full-year revenue is now expected to be in the $470-$490 million range, with adjusted EBITDA now projected to be in the $58-$68 million range, up from a prior $460-$480 million and $55-$65 million, respectively. Initial 2026 guidance called for revenue in the $445-$465 million range and adjusted EBITDA in the $50-$60 million range.
Management Commentary. NN management noted, “Our business continues to build momentum as we ramp up in our key growth markets of Data Center, Defense & Electronics, and Medical, where demand for our solutions remains strong and actively expanding. Our year-to-date results and year-to-go forecast underpin this improved guidance and reflect the steady performance of our growth and cost programs.”
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
CHARLOTTE, N.C., Sept. 22, 2026 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR) a global leader in precision manufacturing, today announced that it is raising its full-year 2026 guidance ranges for Net Sales and Adjusted EBITDA.
Updated Full-Year 2026 Guidance
Metric
Prior Guidance
Updated Guidance
Net Sales
$460 million – $480 million
$470 million – $490 million
Adjusted EBITDA
$55 million – $65 million
$58 million – $68 million
Management’s updated guidance for 2026 Net Sales at midpoint is $480 million, up $58 million, or 14% versus full-year 2025 Net Sales.
Management’s updated guidance for 2026 Adjusted EBITDA at midpoint is $63 million, up $14 million, or 29% versus full-year 2025 Adjusted EBITDA.
Chief Executive Officer Harold Bevis commented, “Our business continues to build momentum as we ramp up in our key growth markets of Data Center, Defense & Electronics, and Medical, where demand for our solutions remains strong and actively expanding. Our year-to-date results and year-to-go forecast underpin this improved guidance and reflect the steady performance our growth and cost programs.
NN is continuing to invest forward in its 5 Pillar growth end markets and this is translating to increased success and higher results. Raising our full-year 2026 guidance for net sales and adjusted EBITDA reflects our confidence in the performance of the business. We remain focused on our balanced plans for delivering profitable growth and improved cost productivity for our customers and shareholders.”
NN, Inc. will provide additional detail and updated guidance when it reports third quarter 2026 results on October 28, 2026.
About NN, Inc. NN, Inc. (NASDAQ: NNBR) is an entrepreneurial manufacturing company specializing in manufacturing micron-toleranced precision metal componentry for high-growth end markets, especially Data Center, Electric Grid, Medical, Defense, and High-Value Vehicle systems. Founded in 1980, NN serves over 700 customers on 4 continents through its 2,550 person workforce operating out of 27 global plants. This footprint enables rapid innovation and global scaled solutions. For more information, visit nninc.com.
Forward Looking Statements This press release may contain forward-looking statements regarding our business, operations, and financial performance. Such statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties. Actual results could differ materially. Please refer to our most recently filed Form 10-K and our Form 10-Q for the period following that Form 10-K, including the risk factors described therein. We undertake no obligation to update any forward-looking statement, except as required by law. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements.
This press release contains certain financial measures not presented in accordance with U.S. generally accepted accounting principles (“GAAP”) such as adjusted EBITDA (the “non-GAAP financial measures”). These non-GAAP financial measures are not calculated in accordance with GAAP and should not be considered in isolation from, or as a substitute for, the most directly comparable GAAP measures, and may not be comparable to similarly titled measures used by other companies. Management uses these non-GAAP financial measures, together with the comparable GAAP measures, to evaluate the Company’s operating performance and underlying business trends across periods on a consistent basis, and to assist in operational and financial decision-making, including with respect to internal budgeting and resource allocation. Reconciliations of each non-GAAP financial measure to its most directly comparable GAAP measure are set forth in the tables accompanying this presentation. A reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures is not provided because the Company cannot reasonably predict certain items necessary for such reconciliation without unreasonable efforts.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
A New Era. NN delivered strong financial performance in the second quarter with record results in many areas. These new sales are higher margin, attached to higher growth rate end markets, and mostly immediate 2026 startup. The Company is achieving many multi-year goals and revising outlooks-including raising full-year guidance- based upon actual results. And, significantly, post-quarter-end management implemented what can only be described as a game-changing restructuring of the capital structure.
Growth. During the quarter, NN secured significant 2026 immediate-supply awards for Data Center liquid cooling products, robotic surgery medical products, and defense products. New business wins through July totaled $80 million. Management increased the full-year new business win goal from $80 million to the $100 million range.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Overview. NN delivered strong financial performance in 2Q26 with record results in many areas. The Company’s 5-pillar growth program is delivering results. New sales are higher margin, attached to higher-growth-rate end markets, and mostly immediate 2026 startup. The second half of 2026 is expected to reflect continued momentum and strong financial performance.
2Q26 Results. Net sales for 2Q26 were $128.7 million, an increase of 19.3% compared to net sales of $107.9 million for the same period in 2025. We were at $116 million. Adjusted EBITDA was $17.9 million, an increase of 36.1% compared to adjusted EBITDA of $13.2 million for 2Q25, primarily driven by improved sales mix and operating performance. We had projected $15 million. Adjusted net income was $5.5 million, or $0.11 per diluted common share, an increase of $4.7 million, or $0.09 per diluted common share, compared to adjusted net income of $0.7 million, or $0.02 per diluted common share, in 2Q25. We were at $2.2 million and $0.04, respectively.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Contract Manufacturing. NN continues to expand into new and adjacent segments, providing the Company with strong growth opportunities, in our view. Most recently, NN successfully entered the Tier 1 contract manufacturing industry for firearm components in the United States market.
Details. NN’s contract manufacturing agreement is to mass-produce completed firearms products for a leading provider of firearms products in the U.S. This new business begins in the third quarter and will continue ramping up through 2028. This new business is expected to add between $12 million and $15 million in sales. Due to the multipart complexity of this new product line, these products are now the highest-priced products in the Company’s portfolio of new products.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
PDF Version New capabilities position Company to pursue additional global defense opportunities
CHARLOTTE, N.C., July 20, 2026 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers, co-develops and manufactures precision components and assemblies with six sigma quality, today announced entry into a brand-new market segment for the company. The company has successfully entered the Tier 1 contract manufacturing industry for firearm components in the United States market. The key components of this successful market entry are:
Turnkey Tier 1 contract manufacturing
Collaborative product development
Additive manufacturing during prototyping
High volume titanium machining
High volume laser welding and assembly
Multiple surface treatment advancements including ceramic surface coating, physical vapor deposition, and nanocomposite diamond-like carbon coating
ATF and FFL compliance program
CMMC Tier 2 certification program
TISAX Tier 2 certification program
ITAR compliance program
Encrypted communications portal that is CMMC, NIST, ITAR and HIPAA compliant
Attendance at weapons shows in the United States
NN has entered into a contract manufacturing agreement to mass produce completed firearms products for a leading provider of firearms products in the United States. This new business for NN was achieved after a multi-year effort that required:
New products
Titanium machining breakthroughs
Surface treatment breakthroughs
Specialized equipment investments
Multi-year collaborative innovation program with a leading brand owner
This new product category is included within NN’s business growth program in Defense & Electronics. This new business begins in Q3 and will continue ramping up through 2028. This new business is expected to add between $12 million to $15 million in sales.
Growth in Defense & Electronics is a key component of the company’s 5-point growth plan. It is a direct application and natural extension of its in-house capabilities into a new market. Including these new wins, NN has won 20+ new programs worth >$30 to $35 million per year over the last 3 years. The company also has an additional pipeline in Defense & Electronics of $75 million of opportunities and has recently hired a Defense industry specialist. Of note, the company is evaluating the manufacturing of munitions for attack drones.
NN has a multi-product game plan within its Defense & Electronics growth program.
Gold and silver plating of critical electronics modules that are contained in advanced weapon systems
Complicated metal fabrications that are key components within guidance and weapon systems
High-end machined parts that are components in firearms (the focus on this article)
The US defense market is at record spending levels with a 5-year outlook to keep growing. Specific to this new set of awards, the US firearms market is growing due to increased emphasis on baseline safety.
The company is employing a large portion of its US footprint to make products for the defense, electronics, and weapons markets. NN now has 8 plants that are ITAR compliant. This enables the company to have a wide aperture onto these markets with a broad product offering of machined parts, stamped parts, plated parts, and assemblies.
Harold Bevis, President and Chief Executive Officer of NN, Inc., commented, “This is a nice advancement for NN’s sales growth program into new markets. It is another direct payoff on the investments we are making to establish premier positions in high-value markets. A tremendous amount of collaborative innovation occurred between the brand owner and NN over the last couple of years on this program. Many prototypes and many samples were iterated in order to arrive at the perfect next-generation product performance.
“We are creating additional competitive barriers by adding distinguishing factory credentials for this new market – ATF and FFL compliance, ITAR compliance, CMMC Tier 2 certification, and TISAX Tier 2 certification. These credentials enhance participation in these markets.
“A fun fact that is due to the multipart complexity of this new product line is that these products are now the highest-priced products in the company’s portfolio of new products. Prices will range from $200 to $500 for each product.”
Bevis concluded, “NN is underway with a multi-year program of sales-driven earnings improvements and this is another building block. Our Defense products growth program is achieving victories. The Defense & Electronics business is already nearly $60 million in sales, and we have a 5-year goal for it to grow to $100 million. It is one of our most profitable segments also due to higher value-add. Our 5 pillars of entrepreneurial break-out growth continue to be focused upon: data center and electric grid, defense and electronics, medical products, high-value vehicle products, and high-value stamped products.
“We will combine this new information along with recent new wins in Data Center and Medical products and adjust 2026 guidance, if needed, for sales, adjusted EBITDA, and New Wins when we release Q2 2026 earnings on August 6. We look forward to discussing this new advancement further at that time.”
Suppressor Pieces and Assembled Product
About NN, Inc. NN, Inc., a global diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has facilities in North America, South America, Europe, and China. For more information about the company and its products, please visit www.nninc.com.
Forward-Looking Statements This press release contains express and implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the future growth of NN’s medical business, including NN’s expectations regarding current and future customers and programs, the size and future outlook of the medical market, including robotics-assisted surgery, NN’s competitive position in the medical market, expected new business wins for 2026, and NN’s 2026 performance and other statements that are not historical facts.
Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “will,” “possible,” “potential,” “predict,” “project”, “achieve,” “growth,” “enable,” “improve,” or the negative of these terms, and similar words, phrases or expressions that convey uncertainty of future events or outcomes. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; competitive influences; risks that current customers will commence or increase captive production; risks of capacity underutilization; quality issues; inflationary pressures and material changes in the costs and availability of raw materials, supply chain shortages and disruptions, the availability of labor and labor distributions along the supply chain; our dependence on certain major customers, some of whom are not parties to long-term agreements (and/or are terminable on short notice); the impact of acquisitions and divestitures, as well as expansion of end markets and product offerings; our ability to hire or retain key personnel; the restrictions contained in our debt agreements; the level of our indebtedness and our ability to financing at favorable rates, if at all, or to refinance existing debt as it matures; our ability to secure, maintain or enforce patents or other appropriate protections for our intellectual property; the impact on climate change on our operations; economic, social and geopolitical instability, military conflict, currency fluctuations, and other risks of doing business outside of the United States; and uncertainty of government policies and actions in respect to global trade and tariffs, including the potential impacts of tariffs on the United States economy, the economy of other countries in which we conduct operations and our industry, cyber liability or potential liability for breaches of our or our service providers’ information technology systems or business operations disruptions. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s filings made with the U.S. Securities and Exchange Commission. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. New risks and uncertainties may emerge from time to time, and it is not possible for the Company to predict their occurrence or how they will affect the Company. The Company qualifies all forward-looking statements by these cautionary statements.
Investor & Media Contact: Joe Caminiti [email protected] 312-445-2870
NN to manufacture critical components for a leading robotic-assisted surgery platform
CHARLOTTE, N.C., July 06, 2026 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers, co-develops and manufactures precision components and assemblies with six sigma quality, today provided an update on developments in its Medical Products business, one of the Company’s key targeted growth markets. The components of the Medical Products growth program are:
Specialized quality control systems in the plants that make medical products
Global footprint in North America, China, South America, Europe
NN has achieved awards to support major OEMs in Ultrasound, Interventional Cardiology, Sports Medicine & Extremity Solutions, and Robotic-Assisted Surgery. Robotic-Assisted Surgery is a new breakthrough area of success and the focus of this press release. NN has now become qualified and has received initial POs tied to a leading robotic-assisted surgery platform. This momentum complements NN’s legacy medical work in surgical instruments, orthopedic tools/components, electrosurgical products, suture-related products, and precision medical components.
A recent and most difficult step to entering the Robot-Assisted Surgery market was passing a critical full-facility audit at NN’s Kentwood, Michigan plant. Successfully passing this audit was made possible by completing a multi-year investment program and installing a new quality system. With this new medical certification now steady-state, a large and well-known new customer has released its first purchase orders to NN, with immediate delivery and ramp-up requirements. This also provides NN with references and an avenue to quote and win additional programs.
With this new customer, the new medical certification, and new medical products, NN’s medical new business pipeline has increased in size by ~$25 million and is now approximately $75 million overall. This is now a meaningful component of NN’s total corporate new business pipeline of >$750 million which includes all products for all markets.
Robotic-assisted surgery is the fastest-growing method of surgical care, expanding at double-digit annual rates in the United States. The underlying growth of this key market reflects a strong secular growth opportunity for precision component suppliers like NN that possess the critical engineering capability, quality systems, and global manufacturing footprint to serve it. NN is uniquely positioned to participate in medical market growth as a qualified manufacturer. NN is actively investing into the medical market with dedicated staff, tradeshow attendance, additional equipment, and new products.
Harold Bevis, President and Chief Executive Officer of NN, Inc., commented, “This is a milestone event for NN’s medical products growth program and a direct payoff on the investments we have made over the last three years to establish a premier presence in this medical market. We needed to upgrade our quality system to the medical level and we have done it.
“Medical Products is one of our five targeted growth markets and we have been very deliberate about building the capabilities required to compete and win. This includes specialized machines, dedicated floor space, certified quality systems, and a dedicated medical team. Passing this full facility quality audit and securing our first newly associated purchase orders to make precision components for a leading robotic surgery platform is a good step forward for NN.”
Bevis continued, “Our precision stainless steel machining expertise supports these new markets well. We are successfully executing on our stated growth goals in the medical products market, and we intend to both grow with this particular customer, as well as more fully participate in the broader medical market.
“This medical products achievement is consistent with our growth program overall. We are partnering for long-term success with OEM category winners. We are successfully building the Company’s business profile in new markets and with new customers. Safety-critical, engineered components are our core value proposition. We support it with a clever team, material science, six sigma quality, and global manufacturing footprint. The medical products achievements announced today, combined with the strong momentum we are experiencing in data center and defense, continue to demonstrate that our entrepreneurial breakout growth program is working well.”
Bevis concluded, “NN is underway with a multi-year program of growing its business into new areas. It is awesome to have the Medical Products portion of the 5 Pillar growth program achieving breakthrough victories. The 5 pillars of break-out growth continue to be: data center and electric grid, defense and electronics, medical products, high-value vehicle products, and high-value stamped products.
We will combine this Medical Product new win information with our recent new wins in Data Center and adjust 2026 sales, adjusted EBITDA, and New Wins guidance, if needed, during NN’s next business and guidance update in August. We look forward to discussing this big advancement during that time.”
About NN, Inc. NN, Inc., a global diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has facilities in North America, South America, Europe, and China. For more information about the company and its products, please visit www.nninc.com.
Forward-Looking Statements This press release contains express and implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the future growth of NN’s medical business, including NN’s expectations regarding current and future customers and programs, the size and future outlook of the medical market, including robotics-assisted surgery, NN’s competitive position in the medical market, expected new business wins for 2026, and NN’s 2026 performance and other statements that are not historical facts.
Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “will,” “possible,” “potential,” “predict,” “project”, “achieve,” “growth,” “enable,” “improve,” or the negative of these terms, and similar words, phrases or expressions that convey uncertainty of future events or outcomes. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; competitive influences; risks that current customers will commence or increase captive production; risks of capacity underutilization; quality issues; inflationary pressures and material changes in the costs and availability of raw materials, supply chain shortages and disruptions, the availability of labor and labor distributions along the supply chain; our dependence on certain major customers, some of whom are not parties to long-term agreements (and/or are terminable on short notice); the impact of acquisitions and divestitures, as well as expansion of end markets and product offerings; our ability to hire or retain key personnel; the restrictions contained in our debt agreements; the level of our indebtedness and our ability to financing at favorable rates, if at all, or to refinance existing debt as it matures; our ability to secure, maintain or enforce patents or other appropriate protections for our intellectual property; the impact on climate change on our operations; economic, social and geopolitical instability, military conflict, currency fluctuations, and other risks of doing business outside of the United States; and uncertainty of government policies and actions in respect to global trade and tariffs, including the potential impacts of tariffs on the United States economy, the economy of other countries in which we conduct operations and our industry, cyber liability or potential liability for breaches of our or our service providers’ information technology systems or business operations disruptions. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s filings made with the U.S. Securities and Exchange Commission. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. New risks and uncertainties may emerge from time to time, and it is not possible for the Company to predict their occurrence or how they will affect the Company. The Company qualifies all forward-looking statements by these cautionary statements.
Investor & Media Contact: Joe Caminiti [email protected] 312-445-2870
Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
A Raise. Yesterday, NN announced it entered into a securities purchase agreement for a private investment in public equity financing (“PIPE”) that is expected to result in gross proceeds of $75.0 million before deducting placement agent fees and offering expenses. The PIPE is expected to close on or about July 2, 2026. The raise should enable NN to restructure a significant part of its balance sheet, positioning the Company for accretive organic growth, in our view, and opening up the potential for accretive M&A.
Details. Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, NN will issue an aggregate of 24,509,804 shares of common stock at a price of $3.06 per share. As of April 27th, NN had 52.8 million common shares outstanding. The shares to be issued under the PIPE will increase the outstanding shares to 77.2 million, a substantial increase in outstanding shares.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
